药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Insulin peglispro
Linagliptin may increase the hypoglycemic activities of Insulin peglispro.
Tetracosactide
Insulin degludec
Linagliptin may increase the hypoglycemic activities of Insulin degludec.
Tetracosactide
NN344
Linagliptin may increase the hypoglycemic activities of NN344.
Tetracosactide
Insulin glulisine
Linagliptin may increase the hypoglycemic activities of Insulin glulisine.
Tetracosactide
Insulin detemir
Linagliptin may increase the hypoglycemic activities of Insulin detemir.
Tetracosactide
Insulin aspart
Linagliptin may increase the hypoglycemic activities of Insulin aspart.
Tetracosactide
Choline salicylate
Choline salicylate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Thiosalicylic acid
Thiosalicylic acid may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Carbaspirin calcium
Carbaspirin calcium may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Guacetisal
Guacetisal may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Nitroaspirin
Nitroaspirin may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Trolamine salicylate
Trolamine salicylate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Methyl salicylate
Methyl salicylate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Phenyl aminosalicylate
Phenyl aminosalicylate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Dersalazine
Dersalazine may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Bismuth subsalicylate
Bismuth subsalicylate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Linagliptin.
Tetracosactide
Levomilnacipran
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Linagliptin.
Tetracosactide
Dapoxetine
The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Linagliptin.